Pinnacle Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-36,104
| Closed | -$3.58M | – | 759 |
|
|
2019
Q3 | $3.58M | Sell |
36,104
-3,182
| -8% | -$302K | 0.08% | 233 |
|
|
2019
Q2 | $3.63M | Sell |
39,286
-432
| -1% | -$41K | 0.09% | 237 |
|
|
2019
Q1 | $3.75M | Sell |
39,718
-3,680
| -8% | -$322K | 0.08% | 237 |
|
|
2018
Q4 | $2.78M | Sell |
43,398
-3,565
| -8% | -$263K | 0.07% | 256 |
|
|
2018
Q3 | $4.2M | Sell |
46,963
-5,919
| -11% | -$523K | 0.09% | 235 |
|
|
2018
Q2 | $4.2M | Buy |
52,882
+1,453
| +3% | +$121K | 0.09% | 237 |
|
|
2018
Q1 | $4.59M | Buy |
51,429
+21,215
| +70% | +$2.04M | 0.09% | 218 |
|
|
2017
Q4 | $3.15M | Buy |
30,214
+18,232
| +152% | +$2.06M | 0.06% | 258 |
|
|
2017
Q3 | $1.75M | Sell |
11,982
-182
| -1% | -$24.8K | 0.03% | 328 |
|
|
2017
Q2 | $1.58M | Buy |
12,164
+2,649
| +28% | +$325K | 0.03% | 335 |
|
|
2017
Q1 | $1.18M | Buy |
9,515
+133
| +1% | +$15.9K | 0.02% | 373 |
|
|
2016
Q4 | $1.09M | Buy |
9,382
+178
| +2% | +$19.8K | 0.02% | 372 |
|
|
2016
Q3 | $962K | Buy |
9,204
+512
| +6% | +$55.4K | 0.02% | 380 |
|
|
2016
Q2 | $857K | Buy |
8,692
+1,815
| +26% | +$188K | 0.02% | 392 |
|
|
2016
Q1 | $688K | Buy |
6,877
+900
| +15% | +$92.7K | 0.01% | 412 |
|
|
2015
Q4 | $716K | Buy |
5,977
+733
| +14% | +$84.8K | 0.02% | 415 |
|
|
2015
Q3 | $567K | Sell |
5,244
-557
| -10% | -$69.1K | 0.01% | 449 |
|
|
2015
Q2 | $671K | Sell |
5,801
-132
| -2% | -$15.1K | 0.01% | 430 |
|
|
2015
Q1 | $684K | Buy |
5,933
+2,800
| +89% | +$335K | 0.01% | 423 |
|
|
2014
Q4 | $350K | Buy |
3,133
+135
| +5% | +$14.2K | 0.01% | 500 |
|
|
2014
Q3 | $284K | Hold |
2,998
| – | – | 0.01% | 541 |
|
|
2014
Q2 | $257K | Sell |
2,998
-360
| -11% | -$27.4K | 0.01% | 543 |
|
|
2014
Q1 | $234K | Buy |
3,358
+516
| +18% | +$40.9K | ﹤0.01% | 540 |
|
|
2013
Q4 | $240K | Buy |
2,842
+100
| +4% | +$7.91K | ﹤0.01% | 547 |
|
|
2013
Q3 | $211K | Sell |
2,742
-694
| -20% | -$48.6K | ﹤0.01% | 539 |
|
|
2013
Q2 | $201K | Buy |
+3,436
| New | +$207K | ﹤0.01% | 523 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Pinnacle Associates's CELG Position: Q4 2019 in Review
Pinnacle Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,104 shares — an estimated $3.58M sold.
Pinnacle Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.59M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Pinnacle Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Pinnacle Associates sold 36,104 Celgene Corp shares in Q4 2019, an estimated $3.58M.
- Pinnacle Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Pinnacle Associates's Celgene Corp position peaked at $4.59M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Pinnacle Associates's 13F filing for Q4 2019, filed 3 Feb 2020.